Equitec Proprietary Markets’s Amgen AMGN Stock Holding History

Equitec Proprietary Markets’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,498	Closed	-$1.28M	–	57
2018 Q1	$1.28M	Buy	+7,498	New	+$1.38M	0.39%	30
2015 Q1	–	Sell	-6,867	Closed	-$1.09M	–	173
2014 Q4	$1.09M	Buy	+6,867	New	+$1.07M	0.05%	89

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Equitec Proprietary Markets's AMGN Position: Q2 2018 in Review

Equitec Proprietary Markets sold out of Amgen (AMGN) in Q2 2018, closing a stake of 7,498 shares — an estimated $1.28M sold.

Equitec Proprietary Markets first reported a position in AMGN in Q4 2014 and held it in 2 quarters. The position peaked at $1.28M in Q1 2018. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

Equitec Proprietary Markets reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
Equitec Proprietary Markets sold 7,498 Amgen shares in Q2 2018, an estimated $1.28M.
Equitec Proprietary Markets first reported a position in Amgen in Q4 2014 and held it in 2 quarters.
Equitec Proprietary Markets's Amgen position peaked at $1.28M in Q1 2018.
1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Equitec Proprietary Markets's 13F filing for Q2 2018, filed 17 Jul 2018.